Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

In silico exploration of 6-sulfonyl-8-nitrobenzothiazinone derivatives as mycobacterium tuberculosis GyrB inhibitors: Molecular docking, md simulation, DFT, and pharmacokinetic studies

2025In Silico Research in BiomedicineJournalOpen access

10.1016/j.insi.2025.100018 Full text11 citations

Authors

7 authors across 3 institutions in 2 countries.

Thomas Aondofa NyijimeFirst authorCorresponding
- Ahmadu Bello University (NG)
Gideon Adamu Shallangwa
- Ahmadu Bello University (NG)
Adamu Uzairu
- Ahmadu Bello University (NG)
Abdullahi Bello Umar
- Ahmadu Bello University (NG)
Muhammad Tukur Ibrahim
- Ahmadu Bello University (NG)
Rohini S. Kavalapure
Ramith RamuSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Phenothiazines and Benzothiazines Synthesis and Activitieslevel 3 · 1.00
Quinazolinone synthesis and applicationslevel 3 · 1.00
Synthesis and biological activitylevel 3 · 1.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · In Silico Research in Biomedicine · 11 citations
https://openalex.org/W4410935359

In silico exploration of 6-sulfonyl-8-nitrobenzothiazinone derivatives as mycobacterium tuberculosis GyrB inhibitors: Molecular docking, md simulation, DFT, and pharmacokinetic studies · Sankore